The ursodeoxycholic acid story in primary biliary cirrhosis.
作者信息
Lim A G, Jazrawi R P, Northfield T C
机构信息
Division of Biochemical Medicine, St George's Hospital Medical School, London.
出版信息
Gut. 1995 Sep;37(3):301-4. doi: 10.1136/gut.37.3.301.
Abstract
摘要
相似文献
1
The ursodeoxycholic acid story in primary biliary cirrhosis.熊去氧胆酸在原发性胆汁性肝硬化中的应用历程
Gut. 1995 Sep;37(3):301-4. doi: 10.1136/gut.37.3.301.
2
[Primary biliary cirrhosis and ursodeoxycholic acid therapy].[原发性胆汁性肝硬化与熊去氧胆酸治疗]
Nihon Naika Gakkai Zasshi. 1996 Mar 10;85(3):399-403.
3
Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.熊去氧胆酸治疗原发性胆汁性肝硬化：过去的经验教训——未来的问题
J Hepatol. 2000 Apr;32(4):685-8. doi: 10.1016/s0168-8278(00)80232-9.
4
Ursodeoxycholic acid for primary biliary cirrhosis.熊去氧胆酸用于原发性胆汁性肝硬化。
Drug Ther Bull. 1999 Apr;37(4):30-2. doi: 10.1136/dtb.1999.37430.
5
Patients and patience: the pitfalls of primary biliary cirrhosis trials.患者与耐心：原发性胆汁性肝硬化试验的陷阱
Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):552-3. doi: 10.1038/ncpgasthep0360.
6
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis.熊去氧胆酸对生化非进展性原发性胆汁性肝硬化实验室肝脏参数的长期影响。
Clin Res Hepatol Gastroenterol. 2011 Jan;35(1):29-33. doi: 10.1016/j.gcb.2010.07.018.
7
Ursodeoxycholic acid for primary biliary cirrhosis.熊去氧胆酸用于原发性胆汁性肝硬化。
Cochrane Database Syst Rev. 2002(1):CD000551. doi: 10.1002/14651858.CD000551.
8
[Medical treatment of chronic cholestasis: ursodeoxycholic acid].[慢性胆汁淤积的医学治疗：熊去氧胆酸]
Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:24-38.
9
Ursodeoxycholic acid for primary biliary cirrhosis.熊去氧胆酸用于原发性胆汁性肝硬化。
Lancet. 2000 Feb 19;355(9204):657-8. doi: 10.1016/S0140-6736(05)72401-6.
10
Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?原发性胆汁性肝硬化患者移植前熊去氧胆酸治疗与肝移植：三赢？
Liver Transpl Surg. 1999 Jul;5(4):334-7. doi: 10.1002/lt.500050403.
引用本文的文献
1
Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.熊去氧胆酸治疗下抗线粒体抗体阳性和阴性原发性胆汁性肝硬化患者的生存率
Dig Dis Sci. 2004 Aug;49(7-8):1190-5. doi: 10.1023/b:ddas.0000037811.48575.da.
2
Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.在原发性胆汁性肝硬化中给予甲基强的松龙可增加胆酸周转率、合成以及胆汁中脱氧胆酸盐浓度。
Dig Dis Sci. 1999 Dec;44(12):2478-83. doi: 10.1023/a:1026687022202.
3
Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.熊去氧胆酸治疗原发性胆汁性肝硬化。一项基于英国单中心人群的为期10年的疗效与生存情况审计。
Postgrad Med J. 1998 Aug;74(874):482-5. doi: 10.1136/pgmj.74.874.482.
本文引用的文献
1
Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.原发性胆汁性肝硬化中的分子模拟。与丙酮酸脱氢酶复合物-E2交叉反应的分子在胆管上皮表达的证据。
J Clin Invest. 1993 Jun;91(6):2653-64. doi: 10.1172/JCI116504.
2
Hepatoprotective properties of ursodeoxycholic acid.熊去氧胆酸的肝脏保护特性。
Gastroenterology. 1993 Jun;104(6):1865-70. doi: 10.1016/0016-5085(93)90672-y.
3
Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.熊去氧胆酸对原发性胆汁性肝硬化早期患者胆汁酸代谢的影响
Dig Dis Sci. 1993 May;38(5):896-902. doi: 10.1007/BF01295917.
4
Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.原发性胆汁性肝硬化患者的血清胆汁酸：熊去氧胆酸治疗的效果
Hepatology. 1993 Apr;17(4):599-604. doi: 10.1002/hep.1840170412.
5
Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].熊去氧胆酸对膜稳定作用的分子机制[见评论]
Gastroenterology. 1993 Jun;104(6):1736-44. doi: 10.1016/0016-5085(93)90653-t.
6
The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells.
Hepatology. 1993 Jul;18(1):165-72.
7
Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.原发性胆汁性肝硬化中，根据疾病严重程度对熊去氧胆酸（UDCA）的不同反应。
Dig Dis Sci. 1994 Jan;39(1):9-14. doi: 10.1007/BF02090053.
8
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.胆汁淤积性肝病中肝脏胆汁酸处理的动力学：熊去氧胆酸的作用
Gastroenterology. 1994 Jan;106(1):134-42. doi: 10.1016/s0016-5085(94)94899-2.
9
Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.熊去氧胆酸与泼尼松联合治疗原发性胆汁性肝硬化。
Neth J Med. 1994 Mar;44(3):84-90.
Zotero 插件